Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 6, 2008, Pages

  Du, Jianfeng ^a   Liu, Jing ^a   Feng, Han Zhong ^b   Hossain, M M ^b   Gobara, Nariman ^a   Zhang, Chi ^a   Li, Yuejin ^a   Jean Charles, Pierre Yves ^a   Jin, Jian Ping ^b   Huang, Xu Pei ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Cardiac relaxation; Doppler echocardiography; Troponin I; Working heart function

Indexed keywords

TROPONIN I; CARDIOTONIC AGENT; DOBUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; GENE MUTATION; HEART FUNCTION; HEART MUSCLE RELAXATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; TRANSGENIC MOUSE; AGE; ANIMAL; CELL SIZE; DIASTOLE; DISEASE COURSE; DRUG EFFECT; ECHOGRAPHY; GENETICS; GENOTYPE; HEART CONTRACTION; HEART FAILURE; HEART OUTPUT; HEART RATE; MUTATION; PATHOLOGY; PHENOTYPE;

AGE FACTORS; ANIMALS; CARDIAC OUTPUT; CARDIOMYOPATHY, RESTRICTIVE; CARDIOTONIC AGENTS; CELL SIZE; DIASTOLE; DISEASE PROGRESSION; DOBUTAMINE; ECHOCARDIOGRAPHY, DOPPLER; GENOTYPE; HEART FAILURE; HEART RATE; MICE; MICE, TRANSGENIC; MUTATION; MYOCARDIAL CONTRACTION; PHENOTYPE; TROPONIN I;

EID: 49249125065     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.91506.2007     Document Type: Article

References (54)

1. Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12: 426-440, 1988.
2. Barbato J, Huang QQ, Hossain MM, Bond M, Jin JP. Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function. J Biol Chem 280: 6602-6609, 2005.
3. Biesiadecki B, Jin JP. Exon skipping in cardiac troponin T of turkeys with inherited dilated cardiomyopathy. J Biol Chem 277: 18459-18468, 2002.
4. Bilgic A, Ozbarlas N, Ozkutlu S, Ozer S, Ozme S. Cardiomyopathies in children. Clinical, epidemiological and prognostic evaluation. Jpn Heart J 31: 789-797, 1990.
5. Chinnaiyan KM, Leff CB, Marsalese DL. Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis and management. Cardiol Rev 12: 314-320, 2004.
6. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 13: 227-239, 2003.
7. 2+-independent mechanical tone and acute myocyte remodeling. Circ Res 100: 1494-1502, 2007.
8. Du J, Zhang C, Liu J, Sidky C, Huang XP. A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. Arch Biochem Biophys 456: 143-150, 2006.
9. Feigenbaum H, Armstrong WF, Ryan T. Evaluation of systolic and diastolic function of the left ventricle. In: Feigenbaum's Echocardiography (6th ed.). Philadelphia, PA: Lippincott Williams & Wilkins, 2005, p. 138-180.
10. Foster DB, Noguchi T, VanBuren P, Murphy AM, Van Eyk JE. C-terminal truncation of cardiac troponin I causes divergent effects on ATPase and force: implications for the pathophysiology of myocardial stunning. Circ Res 93: 917-924, 2003.
11. Garcia MJ, Rodriguez L, Ares M, Griffin BP, Thomas JD. Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol 27: 108-114, 1996.
12. Giannuzzi P, Imparato A, Temporelli PL, de Vito F, Silva PL, Scapellato F, Giodano A. Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23: 1630-1637, 1994.
13. Hirota Y, Shimizu G, Kita Y, Nakayama Y, Suwa M, Kawamura K, Nagate S, Sawayama T, Izumi T, Nakano T. Spectrum of restrictive cardiomyopathy: report of the national survey in Japan. Am Heart J 120: 188-194, 1990.
14. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 113: e858-e862, 2006.
15. Ho CY, Sweitzer NK, McDonough B, Marron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105: 2992-2997, 2002.
16. Huang QQ, Feng H, Liu J, Du J, Stull LB, Moravec C, Huang XP, Jin JP. Coexpression of skeletal and cardiac troponin T decreases mouse cardiac function. Am J Physiol Cell Physiol 294: C213-C222, 2008.
17. Huang XP, Du J. Troponin I, cardiac diastolic dysfunction and restrictive cardiomyopathy. Acta Pharmacol Sin 25: 1569-1575, 2004.
18. Huang XP, Pi Y, Lee KJ, Henkel AS, Gregg RG, Powers PA, Walker JW. Cardiac troponin I gene knockout, a mouse model of myocardial troponin I deficiency. Circ Res 84: 1-8, 1999.
19. James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J. Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 805-811, 2000.
20. 2+-modulated allosteric domain in the troponin complex. Biochemistry 40: 2623-2631, 2001.
21. Kaski JP, Burch M, Elliott PM. Mutations in the cardiac troponin C gene are a cause of idiopathic dilated cardiomyopathy in childhood. Cardiol Young 17: 675-677, 2007.
22. Kimura A, Harada H, Park JE, Hishi H, Satoh M, Takahashi M, Hiroi S, Sasaoka T, Ohbuchi N, Nakamura T, Koyanagi T, Hwang TH, Choo JA, Chung KS, Hasegawa A, Nagai R, Okazaki O, Nakamura H, Matsuzaki M, Sakamoto T, Toshima H, Koga Y, Imaizumi T, Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet 16: 379-382, 1997.
23. Kokado H, Shimizu M, Yoshio H, Ino H, Okeie K, Emoto Y, Matsuyama T, Yamaguchi M, Yasuda T, Fujino N, Ito H, Mabuchi H. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 102: 663-669, 2000.
24. Liao P, Geogakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y. The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98: 12283-12288, 2001.
25. Liu J, Du J, Zhang C, Walker JW, Huang XP. Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice. Am J Physiol Heart Circ Physiol 293: H1273-H1281, 2007.
26. 2+ desensitization. J Mol Cell Cardiol 35: 1421-1427, 2003.
27. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33: 655-670, 2001.
28. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res 94: 146-158, 2004.
29. Mogensen J. Troponin mutations in cardiomyopathies. Adv Exp Med Biol 592: 201-226, 2007.
30. Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutation. J Clin Invest 111: 209-216, 2003.
31. Morner S, Richard P, Kazzam E, Hainque B, Schwartz K, Waldenstrom A. Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 521-525, 2000.
32. Nacruth R, Barretto AC, Mady C, Da Luz PL, Pileggi F. Idiopathic restrictive cardiomyopathy. Arq Bras Cardiol 61: 175-180, 1993.
33. Ohtsuki I. Troponin: structure, function and dysfunction. Adv Exp Med Biol 592: 21-36, 2007.
34. Peddy SB, Vricella LA, Crosson JE, Oswald GL, Cohn RD, Cameron DE, Valle D, Loeys BL. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics 117: 1830-1833, 2006.
35. 2+ sensitivity of force development and impairs the inhibitory properties of troponin. J Biol Chem 283: 2156-2166, 2007.
36. Preston LC, Watkins H, Redwood CS. A revised method of troponin exchange in permeabilised cardiac trabeculae using vanadate: functional consequences of a HCM-causing mutation in troponin I. J Muscle Res Cell Motil 27: 585-590, 2006.
37. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 15: 167-184, 2002.
38. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res 44: 20-36, 1999.
39. Rivenes SM, Kerrney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 102: 876-882, 2000.
40. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
41. Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X, Hewett TE, Klevitsky R, Hayes E, Warshaw DM, Robbins J. In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87: 296-302, 2000.
42. Sanbe A, James J, Tuzcu V, Nas S, Martin L, Gulick J, Osinska H, Sakthivel S, Klevitsky R, Ginsburg KS, Bers DM, Zinman B, Lakatta EG, Robbins J. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation 111: 2330-2338, 2005.
43. Seidman JG, Seidman C. The genetic basis for cardiomyopathy from mutation identification to mechanistic paradigm. Cell 104: 557-567, 2001.
44. 2+ sensitivity increase. J Physiol 15: 201-213, 2006.
45. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30: 474-480, 1997.
46. Solaro RJ. Modulation of cardiac myofilament activity by protein phosphorylation. In Handbook of Physiology. The Cardiovascular System. The Heart. Bethesda, MD: Am Physiol Soc, 2001, sect 2, vol 1, p. 264-300.
47. Srinivasan S, Baldwin HS, Aristizabal O, Kwee L, Labow M, Artman M, Turnbull DH. Noninvasive, in utero imaging of mouse embryonic heart development with 40-MHz echocardiography. Circulation 98: 912-918, 1998.
48. Takahashi-Yanaga F, Morimoto S, Harada K, Minakami R, Shiraishi F, Ohta M, Lu QW, Sasaguri I, Ohtsuki I. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 3: 2095-2107, 2002.
49. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol 58: 447-481, 1996.
50. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res 82: 261-271, 1998.
51. 2+-sensitization and potentialation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy. J Biol Chem 274: 8806-8812, 1999.
52. 2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun 338: 1519-1526, 2005.
53. Zhou YQ, Foster FS, Parkes R, Adamson SL. Developmental changes in left and right ventricular diastolic filling patterns in mice. Am J Physiol Heart Circ Physiol 285: H1563-H1575, 2003.
54. Zhou YQ, Zhu Y, Bishop J, Davidson L, Henkelman RM, Bruneau BG, Foster FS. Abnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oran syndrome. Am J Physiol Heart Circ Physiol 289: H992-H1001, 2005.